From Microscopes to Multimodal AI: Techcyte’s Fusion Platform with CEO Ben Cahoon

In this episode of Pathology News Talks, we sit down with Ben Cahoon, CEO of Techcyte, one of the most innovative leaders in the digital pathology space.Ben shares the journey from his early days at Intel to building Techcyte — a company redefining pathology through the Fusion Platform, which unites anatomic and clinical pathology in a single workflow.We dive into:💡 How Techcyte evolved from environmental and veterinary labs to human clinical and anatomic pathology🧬 The power of combining AI, workflow, and data integration🔬 The path to true multimodal pathology — merging digital slides, molecular data, and patient history⚙️ What “scanner agnostic” really means and why DICOM compliance is key🧠 Why the future of diagnostics isn’t AI versus humans, but AI with humansWhether you’re in pathology, informatics, or digital health, this one’s packed with insights on where our industry is heading and how software platforms like Fusion are accelerating that shift.